GIM
Granahan Investment Management Portfolio holdings
AUM
$2.46B
This Quarter Return
+10.75%
1 Year Return
+66.36%
3 Year Return
+183.04%
5 Year Return
+309.49%
10 Year Return
+1,968.52%
AUM
$4.72B
AUM Growth
+$4.72B
(+5.8%)
Cap. Flow
+$14.5M
Cap. Flow
% of AUM
0.31%
Top 10 Holdings %
Top 10 Hldgs %
33.63%
Holding
214
New
22
Increased
84
Reduced
85
Closed
23
Top Buys
| 1 |
Kulicke & Soffa
KLIC
|
$52.8M |
| 2 |
Chart Industries
GTLS
|
$49.7M |
| 3 |
Cricut
CRCT
|
$48.4M |
| 4 |
Bumble
BMBL
|
$39.8M |
| 5 |
TWOU
2U, Inc.
TWOU
|
$38.7M |
Top Sells
| 1 |
Magnite
MGNI
|
$66.6M |
| 2 |
Sprout Social
SPT
|
$64.8M |
| 3 |
eHealth
EHTH
|
$51.7M |
| 4 |
HubSpot
HUBS
|
$45.5M |
| 5 |
Vericel Corp
VCEL
|
$39.8M |
Sector Composition
| 1 | Technology | 37.51% |
| 2 | Healthcare | 17.62% |
| 3 | Industrials | 14.66% |
| 4 | Consumer Discretionary | 10.58% |
| 5 | Communication Services | 6.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KIN
151
DELISTED
Kindred Biosciences, Inc.
KIN
| $4.13M | 0.09% |
831,029
+78,207
| +10% | +$389K |
|
152
Onto Innovation
ONTO
$5.19B
| $3.94M | 0.08% |
59,908
+1,755
| +3% | +$115K |
|
153
Kinsale Capital Group
KNSL
$10.7B
| $3.89M | 0.08% |
23,625
+9,454
| +67% | +$1.56M |
|
154
Radware
RDWR
$1.08B
| $3.72M | 0.08% |
142,624
+11,835
| +9% | +$309K |
|
155
WIX.com
WIX
$7.85B
| $3.54M | 0.08% |
12,662
+5,523
| +77% | +$1.54M |
|
|
JNCE
156
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $3.48M | 0.07% |
338,969
-61,044
| -15% | -$627K |
|
|
ABMD
157
DELISTED
Abiomed Inc
ABMD
| $3.27M | 0.07% |
10,260
-2,792
| -21% | -$890K |
|
158
Qualys
QLYS
$4.9B
| $3.19M | 0.07% |
30,432
+1,174
| +4% | +$123K |
|
159
Zscaler
ZS
$43.1B
| $3.05M | 0.06% |
17,741
-133,597
| -88% | -$22.9M |
|
160
Silicon Laboratories
SLAB
$4.41B
| $3.03M | 0.06% |
21,508
+961
| +5% | +$136K |
|
161
Monolithic Power Systems
MPWR
$40B
| $2.76M | 0.06% |
7,805
-90
| -1% | -$31.8K |
|
162
Sangamo Therapeutics
SGMO
$157M
| $2.74M | 0.06% |
218,468
-39,508
| -15% | -$495K |
|
163
LifeMD
LFMD
$294M
| $2.65M | 0.06% |
+167,358
| New | +$2.65M |
|
164
Protolabs
PRLB
$1.19B
| $2.58M | 0.05% |
21,227
+2,162
| +11% | +$263K |
|
165
Neurogene
NGNE
$264M
| $2.47M | 0.05% |
200,518
-45,781
| -19% | -$563K |
|
|
PFPT
166
DELISTED
Proofpoint, Inc.
PFPT
| $2.43M | 0.05% |
19,341
+1,302
| +7% | +$164K |
|
|
NEWR
167
DELISTED
New Relic, Inc.
NEWR
| $2.39M | 0.05% |
38,945
+2,472
| +7% | +$152K |
|
|
GAN
168
DELISTED
GAN Ltd
GAN
| $2.38M | 0.05% |
130,593
-114,546
| -47% | -$2.08M |
|
169
Seer Inc
SEER
$115M
| $2.34M | 0.05% |
+46,735
| New | +$2.34M |
|
|
170
HubSpot
HUBS
$25.5B
| $2.2M | 0.05% |
4,848
-100,156
| -95% | -$45.5M |
|
171
Xeris Biopharma Holdings
XERS
$1.26B
| $1.96M | 0.04% |
433,710
+121,120
| +39% | +$546K |
|
|
AUTL
172
Autolus Therapeutics
AUTL
$399M
| $1.95M | 0.04% |
340,947
-124,848
| -27% | -$716K |
|
173
CyberArk
CYBR
$22.8B
| $1.84M | 0.04% |
14,232
-11,317
| -44% | -$1.46M |
|
174
RingCentral
RNG
$2.76B
| $1.74M | 0.04% |
5,824
+235
| +4% | +$70K |
|
175
BlackLine
BL
$3.36B
| $1.73M | 0.04% |
15,936
-317,991
| -95% | -$34.5M |
|